Rades, D.; Streubel, M.K.; Staackmann, C.; Doehring, L.; Rody, A.; Normann Haverberg, M.J.; Ballegaard, M.
A New Scoring System Administered by Patients to Identify Moderate-to-Severe Chemotherapy-Induced Peripheral Neuropathy: Final Results of the NEURO-BREAC Trial. Cancers 2026, 18, 835.
https://doi.org/10.3390/cancers18050835
AMA Style
Rades D, Streubel MK, Staackmann C, Doehring L, Rody A, Normann Haverberg MJ, Ballegaard M.
A New Scoring System Administered by Patients to Identify Moderate-to-Severe Chemotherapy-Induced Peripheral Neuropathy: Final Results of the NEURO-BREAC Trial. Cancers. 2026; 18(5):835.
https://doi.org/10.3390/cancers18050835
Chicago/Turabian Style
Rades, Dirk, Maria Karolin Streubel, Christian Staackmann, Laura Doehring, Achim Rody, Maria Joy Normann Haverberg, and Martin Ballegaard.
2026. "A New Scoring System Administered by Patients to Identify Moderate-to-Severe Chemotherapy-Induced Peripheral Neuropathy: Final Results of the NEURO-BREAC Trial" Cancers 18, no. 5: 835.
https://doi.org/10.3390/cancers18050835
APA Style
Rades, D., Streubel, M. K., Staackmann, C., Doehring, L., Rody, A., Normann Haverberg, M. J., & Ballegaard, M.
(2026). A New Scoring System Administered by Patients to Identify Moderate-to-Severe Chemotherapy-Induced Peripheral Neuropathy: Final Results of the NEURO-BREAC Trial. Cancers, 18(5), 835.
https://doi.org/10.3390/cancers18050835
